Ask AI

Could It Be MASH? Early Detection and Intervention to Improve Metabolic Outcomes

Gain in-depth knowledge on metabolic dysfunction–associated steatotic liver disease (MASLD) or metabolic dysfunction–associate steatohepatitis (MASH) as well as expert-informed strategies to screen for, risk stratify, and implement the latest treatment guidance and emerging therapies based on current evidence, through expert-written ClinicalThought commentaries, downloadable slides, and an on-demand webcast.

Share

Program Content

Activities

Call to Action in MASH Management
Call to Action in MASH Management: Addressing Persistent Clinical Practice Gaps to Improve Metabolic Outcomes
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 12, 2025

Expires: May 11, 2026

Practical challenges in MASH Care
Practical Challenges in MASH Care: Expert Guidance in Risk Stratification, Treatment Selection, and Comorbidity Management
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 16, 2025

Expires: July 15, 2026

Activities

Could It Be MASLD or MASH slides
Could It Be MASH? Early Detection and Intervention to Improve Metabolic Outcomes
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 17, 2025

Expires: June 16, 2026

Activities

Could it be MASH webcast
Could It Be MASH? Early Detection and Intervention to Improve Metabolic Outcomes
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 07, 2025

Expires: July 06, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Novo Nordisk.

Boehringer Ingelheim Pharmaceuticals, Inc.

Novo Nordisk